|
|
| 21 Sep 2026 | 02:09 IST |
|
Bajaj Finserv Healthcare Fund - Regular (IDCW) |
|
|
|
|
|
|
|
| NAV Details |
| NAV Date : |
18-Sep-26 |
| NAV [Rs]: |
11.90 |
| Buy/Resale Price [Rs] : |
0.00 |
| Sell/Repurchase Price [Rs] : |
0.00 |
| Max Entry Load % : |
0.00 |
| Max Exit Load % : |
0.00 |
|
|
|
|
|
|
|
|
| Quantum of Dividend % |
NA |
NA |
| Date |
NA |
NA |
|
|
|
|
|
|
| Tax benefits : |
|
| Min. Investment(Rs.) : |
500 |
| Increm.Investment(Rs.) : |
100 |
|
|
|
|
|
| Statistical Ratios |
What
is Beta ?
Beta is a measure of the volatility of the portfolio to that of the index. In
simple words it shows the movement of the portfolio in comparison. The Higher
the Beta, higher the volatility of the scheme to the index. If its greater
than1 , then the portfolio is highly volatile to the movemnts in the index. If
the beta is lesser than 1 , then scheme is less volatile to the index and beta
which is close to 1 implies that the scheme is closely following the index.
|
| 0.7545 |
4.8759 |
0.3993 |
10.6059 |
0.1454 |
|
|
|
|
Divi's Lab.
|
10.55
|
|
Sun Pharma.Inds.
|
8.21
|
|
Rubicon Research
|
6.81
|
|
Piramal Pharma
|
6.72
|
|
Aurobindo Pharma
|
6.18
|
|
Apollo Hospitals
|
6.00
|
|
Torrent Pharma.
|
5.03
|
|
Neuland Labs.
|
4.11
|
|
Emcure Pharma
|
3.84
|
|
Max Healthcare
|
3.35
|
|
Fortis Health.
|
2.69
|
|
Zydus Lifesci.
|
2.56
|
|
Ipca Labs.
|
2.46
|
|
Laurus Labs
|
2.36
|
|
Vijaya Diagnost.
|
2.31
|
|
Zydus Wellness
|
2.27
|
|
Senores Pharma.
|
2.15
|
|
Shaily Engineer.
|
2.00
|
|
Glaxosmi. Pharma
|
1.79
|
|
Glenmark Pharma.
|
1.70
|
|
Dr Lal Pathlabs
|
1.68
|
|
Sanofi Consumer
|
1.41
|
|
Cipla
|
1.39
|
|
Dr Reddy's Labs
|
1.28
|
|
Biocon
|
1.16
|
|
Navin Fluo.Intl.
|
0.99
|
|
Krishna Institu.
|
0.93
|
|
Turtlemint Finte
|
0.92
|
|
Medi Assist Ser.
|
0.82
|
|
OneSource Speci.
|
0.82
|
|
Jubilant Pharmo
|
0.76
|
|
MTAR Technologie
|
0.26
|
|
Sumitomo Chemi.
|
0.25
|
|
Neogen Chemicals
|
0.21
|
|
C C I
|
2.12
|
|
Net CA & Others
|
0.61
|
|
Bajaj Finserv Money Market Fund - Direct (G)
|
1.30
|
|
|
|
|
|
|
Asset Allocation
|
|
|
|
 |
|